STOCK TITAN

Enfusion, Inc. - ENFN STOCK NEWS

Welcome to our dedicated page for Enfusion news (Ticker: ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.

Enfusion, Inc. (symbol: ENFN) is a pioneering provider of cloud-based portfolio management and risk systems, headquartered in Chicago, Illinois. With branch offices in New York, as well as wholly-owned subsidiaries in London and Hong Kong, Enfusion stands at the forefront of delivering innovative solutions to clients within the financial services industry. Their advanced software as a service (SaaS) platform empowers investment managers by unifying mission-critical systems and providing a single dataset for real-time performance, risk calculations, and accounting of complex financial products.

Enfusion's core business revolves around transforming the investment management industry by eliminating technology and information barriers, allowing investment managers to make informed decisions swiftly and efficiently. The company's solutions simplify investment and operational workflows, coalescing data into a single source of truth. This integrated approach helps clients manage over $90 billion in assets across some of the world's largest and most respected hedge funds.

Enfusion's recent achievements highlight its exceptional growth trajectory. The company has expanded its operations significantly, with maximum revenue generation from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa. Their innovative platform is trusted by numerous global clients for its real-time performance and robust risk management capabilities.

Enfusion continues to innovate and refine its offerings. Some of their current projects include enhancing their cloud-based solutions to further streamline investment processes and improve data accuracy. The company also emphasizes strong partnerships and collaboration with other industry leaders to bring the latest technological advancements to their clients.

Financially, Enfusion is on solid footing, experiencing rapid growth and affirming its position as a leader in the investment management software industry. The company's client base spans across the globe, relying on Enfusion's cutting-edge solutions to navigate the complexities of financial management.

Overall, Enfusion, Inc. is a crucial player in the financial services industry, known for its commitment to innovation, client satisfaction, and delivering value through state-of-the-art technology.

Rhea-AI Summary

Enfusion, Inc. (NYSE: ENFN), a leading provider of cloud-native investment management software, announced participation in key investor events. CEO Thomas Kim and CFO Steve Dorton will represent Enfusion at the 42nd Annual Growth Stock Conference on June 6, 2022, the Bank of America Global Technology Conference on June 8, 2022, and the Morgan Stanley US Financials, Payments & CRE Conference on June 13, 2022. Enfusion aims to enhance data-driven intelligence across investment management through its software platform, serving over 730 investment managers globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
conferences
-
Rhea-AI Summary

Enfusion, a leader in cloud-native investment management software, will release its Q1 fiscal year 2022 financial results on May 12, 2022, after U.S. markets close. Following this, the company will conduct a conference call at 2:00 PM PT (5:00 PM ET) to discuss results and provide financial guidance. The call can be accessed via specific dial-in numbers, and a live webcast will also be available on Enfusion's Investor Relations page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.95%
Tags
-
Rhea-AI Summary

Plate IQ appoints Andy Roberts as chairman of the board to accelerate its growth in the hospitality software and payments sector. With over 40 years of B2B payments experience, Roberts previously led VPay and Fleet One. His leadership is expected to enhance Plate IQ's strategy in digital payments, targeting verticals like restaurants and hotels. The company processes over $1 billion in vendor payments annually and serves more than 20,000 customers. This appointment is seen as pivotal for capitalizing on the shift to automated workflows amid ongoing labor shortages.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.34%
Tags
management
Rhea-AI Summary

Enfusion reported strong fourth-quarter revenue growth of 41% year-over-year, totaling $31.9 million. The company's Platform Subscriptions revenue rose 39% to $28.9 million, driven by new client additions and existing client growth. Despite the revenue increase, Enfusion posted a net loss of $293.9 million for the quarter, compared to a net income of $12.2 million a year earlier. For 2022, Enfusion anticipates total revenue between $147 million and $150 million, with a projected Adjusted EBITDA of $32.8 million to $33.8 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.67%
Tags
none
-
Rhea-AI Summary

FTV Capital has successfully closed FTV VII, its largest fund to date, with commitments of $2.3 billion. This oversubscribed fund will enable FTV to invest in high-growth companies, particularly within enterprise technology and financial services. So far, FTV has raised $6.2 billion across its funds, with over $4 billion invested in 130 companies. Notable portfolio companies include Enfusion (NYSE: ENFN) and Globant (NYSE: GLOB). The firm aims to continue driving growth for its portfolio through strategic investments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
none
-
Rhea-AI Summary

Enfusion, a leader in cloud-native investment management software, will release its fourth quarter fiscal year 2021 financial results post-market on March 24, 2022. A conference call will follow at 2:00 PM PT / 5:00 PM ET to discuss results and offer financial guidance. Investors can access the call by dialing (844) 200-6205 domestically or (929) 526-1599 internationally, using conference ID 738165. Enfusion serves over 650 investment managers globally, facilitating real-time data-driven intelligence across all office teams.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
Rhea-AI Summary

Enfusion, Inc. (NYSE: ENFN) announces the retirement of founder Tarek Hammoud from its Board of Directors. Hammoud, who founded the company over 25 years ago, expressed pride in the firm's achievements and confidence in its leadership team for future growth. CEO Thomas Kim praised Hammoud's contributions and emphasized the importance of continuing the company's strategic initiatives. Enfusion provides cloud-native investment management software services, partnering with over 650 investment managers globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.78%
Tags
none
-
Rhea-AI Summary

Enfusion, Inc. (NYSE: ENFN) has announced the promotion of Iris Xinwei Wang to Chief Strategy Officer and Lotte Tønsberg to Head of Sales for EMEA. These promotions underscore Enfusion’s commitment to global expansion and internal talent development. Iris, based in New York, will drive strategic initiatives and has a robust background in strategy, including tenure at Bridgewater Associates and Boston Consulting Group. Lotte will focus on business development across Europe, the Middle East, and Africa, building on her successful track record since joining Enfusion in 2020.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.66%
Tags
none
Rhea-AI Summary

Enfusion, Inc. has partnered with Coinbase Global Inc. to integrate systems for seamless cryptocurrency trading, marking Coinbase's first collaboration with an OEMS provider. This connection will enable financial institutions to view and trade crypto alongside traditional assets using Enfusion's platform. Expected to be completed in Q2 2022, this integration aims to meet rising institutional demand for crypto exposure. Enfusion supports diverse asset classes and has established itself as a leader in investment management software.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.75%
Tags
none

FAQ

What is the current stock price of Enfusion (ENFN)?

The current stock price of Enfusion (ENFN) is $10.63 as of December 20, 2024.

What is the market cap of Enfusion (ENFN)?

The market cap of Enfusion (ENFN) is approximately 987.6M.

What does Enfusion, Inc. do?

Enfusion, Inc. provides cloud-based portfolio management and risk systems for the financial services industry.

Where is Enfusion headquartered?

Enfusion is headquartered in Chicago, Illinois.

What is Enfusion's core business focus?

Enfusion focuses on transforming the investment management industry by eliminating technology and information barriers.

How much in assets do Enfusion's clients manage?

Enfusion's clients manage over $90 billion in assets.

In which regions does Enfusion generate the most revenue?

Enfusion generates the most revenue from the Americas, followed by Asia Pacific and EMEA regions.

What recent achievements has Enfusion made?

Enfusion has seen exceptional growth and expanded its global operations significantly.

What kind of clients does Enfusion serve?

Enfusion serves global clients, including some of the world’s largest and most respected hedge funds.

How does Enfusion simplify investment and operational workflows?

Enfusion simplifies workflows by unifying mission-critical systems and providing a single dataset for accurate data management.

What are some current projects Enfusion is working on?

Enfusion is working on enhancing cloud-based solutions to streamline investment processes and improve data accuracy.

What is Enfusion's market position?

Enfusion is a leader in the financial services industry, known for its commitment to innovation and client satisfaction.

Enfusion, Inc.

NYSE:ENFN

ENFN Rankings

ENFN Stock Data

987.60M
86.77M
5.52%
96.86%
1.08%
Software - Application
Services-prepackaged Software
Link
United States of America
CHICAGO